Assignee
ELIGO BIOSCIENCE
FR·36 granted patents·17 pending applications·46 citations·filing 2018–2025
Top patents by PatentIndex Score
53 records- 0198US11633348B2Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2022·Granted Apr 25, 2023·4 cites·15 claims
- 0297US11541106B2Method for killing bacteria with an engineered postbioticELIGO BIOSCIENCE·Filed 2022·Granted Jan 3, 2023·7 cites·20 claims
- 0397US11236133B2Chimeric receptor binding proteins for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2020·Granted Feb 1, 2022·5 cites·21 claims
- 0496US11078490B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2020·Granted Aug 3, 2021·3 cites·20 claims
- 0595US11746352B2Microbiome modulation of a host by delivery of DNA payloads with minimized spreadELIGO BIOSCIENCE·Filed 2021·Granted Sep 5, 2023·3 cites·10 claims
- 0694US11739304B2Production of lytic phagesELIGO BIOSCIENCE·Filed 2022·Granted Aug 29, 2023·2 cites·15 claims
- 0794US11224621B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2021·Granted Jan 18, 2022·4 cites·19 claims
- 0893US11839645B2Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2022·Granted Dec 12, 2023·1 cites·13 claims
- 0993US11690880B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2022·Granted Jul 4, 2023·3 cites·19 claims
- 1092US11512116B2Chimeric receptor binding proteins for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2021·Granted Nov 29, 2022·1 cites·26 claims
- 1192US10808254B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2019·Granted Oct 20, 2020·4 cites·19 claims
- 1291US11534467B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2022·Granted Dec 27, 2022·1 cites·23 claims
- 1389US12460216B2Phage-derived particles for in situ delivery of DNA payload into C. acnes populationELIGO BIOSCIENCE·Filed 2024·Granted Nov 4, 2025·0 cites·17 claims
- 1489US11208437B2Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2019·Granted Dec 28, 2021·3 cites·27 claims
- 1588US12454696B2Cutibacterium acnes recombinant phages encoding a human proteinELIGO BIOSCIENCE·Filed 2023·Granted Oct 28, 2025·0 cites·15 claims
- 1688US11970701B2Phage-derived particles for in situ delivery of DNA payload into C. acnes populationELIGO BIOSCIENCE·Filed 2023·Granted Apr 30, 2024·0 cites·8 claims
- 1788US11473093B2Cutibacterium acnes recombinant phages, method of production and uses thereofELIGO BIOSCIENCE·Filed 2021·Granted Oct 18, 2022·1 cites·4 claims
- 1887US11376286B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2021·Granted Jul 5, 2022·1 cites·18 claims
- 1987US2024218380A1Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 2086US2024182870A1Production bacterial cells and use thereof in production methodsELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 2186US2024247238A1Production of lytic phagesELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 2285US11952595B2Production of lytic phagesELIGO BIOSCIENCE·Filed 2023·Granted Apr 9, 2024·0 cites·19 claims
- 2385US11939598B2Production bacterial cells and use thereof in production methodsELIGO BIOSCIENCE·Filed 2023·Granted Mar 26, 2024·0 cites·16 claims
- 2484US11124776B2Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereofELIGO BIOSCIENCE·Filed 2019·Granted Sep 21, 2021·2 cites·17 claims
- 2583US11840695B2Recombinant C. acnes phages comprising transgenesELIGO BIOSCIENCE·Filed 2022·Granted Dec 12, 2023·0 cites·5 claims
- 2682US12214070B2Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2023·Granted Feb 4, 2025·0 cites·15 claims
- 2781US2023279058A1Chimeric receptor binding proteins for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2023·Application pending·0 cites
- 2880US11697802B2Production bacterial cells and use thereof in production methodsELIGO BIOSCIENCE·Filed 2022·Granted Jul 11, 2023·0 cites·9 claims
- 2980US11584918B2Transcriptional control in prokaryotic cells using DNA-binding repressorsELIGO BIOSCIENCE·Filed 2020·Granted Feb 21, 2023·1 cites·19 claims
- 3080US2023330157A1Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2023·Application pending·0 cites
- 3180US2024209326A1Bacterial delivery vehicle, process of production and uses thereofELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 3279US11820989B2Phage-derived particles for in situ delivery of DNA payload into C. acnes populationELIGO BIOSCIENCE·Filed 2021·Granted Nov 21, 2023·0 cites·18 claims
- 3378US11970716B2Transcriptional control in prokaryotic cells using DNA-binding repressorsELIGO BIOSCIENCE·Filed 2023·Granted Apr 30, 2024·0 cites·25 claims
- 3478US11946056B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2021·Granted Apr 2, 2024·0 cites·15 claims
- 3573US11952594B2Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereofELIGO BIOSCIENCE·Filed 2021·Granted Apr 9, 2024·0 cites·15 claims
- 3673US11661443B2Chimeric receptor binding proteins for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2019·Granted May 30, 2023·0 cites·11 claims
- 3770US12098372B2Microbiome modulation of a host by delivery of DNA payloads with minimized spreadELIGO BIOSCIENCE·Filed 2023·Granted Sep 24, 2024·0 cites·8 claims
- 3869US11905516B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2018·Granted Feb 20, 2024·0 cites·20 claims
- 3968US2023226129A1Elimination of colonic bacterial driving lethal inflammatory cardiomyopathyELIGO BIOSCIENCE·Filed 2023·Application pending·0 cites
- 4066US2025144006A1Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2025·Application pending·0 cites
- 4165US11617773B2Elimination of colonic bacterial driving lethal inflammatory cardiomyopathyELIGO BIOSCIENCE·Filed 2021·Granted Apr 4, 2023·0 cites·7 claims
- 4265US2023112827A1Bacterial delivery vehicles comprising tracer nucleic acid sequencesELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 4365US2023114520A1Engineered bifidobacterium strains comprising a transgeneELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 4463US11584781B2Chimeric receptor binding proteins resistant to proteolytic degradationELIGO BIOSCIENCE·Filed 2021·Granted Feb 21, 2023·0 cites·17 claims
- 4561US11421222B2Bacterial delivery vehicles comprising tracer nucleic acid sequencesELIGO BIOSCIENCE·Filed 2020·Granted Aug 23, 2022·0 cites·25 claims
- 4661US2023134572A1Chimeric receptor binding proteins resistant to proteolytic degradationELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 4760US2023235361A1Method of containment of nucleic acid vectors introduced in a microbiome populationELIGO BIOSCIENCE·Filed 2021·Application pending·0 cites
- 4859US2023126159A1Engineered bacterial strains comprising a transgeneELIGO BIOSCIENCE·Filed 2022·Application pending·0 cites
- 4958US2022064223A1Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehiclesELIGO BIOSCIENCE·Filed 2021·Application pending·0 cites
- 5057US12414962B2Method for treating C. acnes bacteria-associated diseasesELIGO BIOSCIENCE·Filed 2024·Granted Sep 16, 2025·0 cites·19 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ELIGO BIOSCIENCE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →